Opko Health to Acquire Bio-Reference Laboratories
The transaction, expected for completion later this year, is valued at approximately $1.47 billion.
Read MorePosted by Elaine Sanchez Wilson | Jun 9, 2015 | Cancer |
The transaction, expected for completion later this year, is valued at approximately $1.47 billion.
Read MorePosted by Steve Halasey | Dec 9, 2014 | Research |
Clinical study presented at the Society of Urologic Oncology annual meeting validates active surveillance threshold using Prolaris score.
Read MorePosted by Steve Halasey | Aug 25, 2014 | Cancer |
CAP ’14, the College of American Pathologists annual meeting, September 7–10, will feature advances in molecular medicine, genetic testing, and laboratory technologies.
Read MorePosted by Steve Halasey | Jul 15, 2014 | Cancer |
bioMerieux sepsis facility expansion will help address the global public health threat of sepsis and meet the related demand for microbial detection.
Read MorePosted by Jenny Lower | Jun 3, 2014 | Electrolytes, Uncategorized |
New products include the Hematek 3000 hematology analyzer from Siemens Healthcare Diagnostics, CoolCell alcohol-free cell-freezing containers from Biocision, and the Prostate Health Index from Beckman Coulter Diagnostics.
Read More